Gastric cancer peritoneal metastasis (GCPM)

Clinical trials for Gastric cancer peritoneal metastasis (GCPM) explained in plain language.

Never miss a new study

Get alerted when new Gastric cancer peritoneal metastasis (GCPM) trials appear

Sign up with your email to follow new studies for Gastric cancer peritoneal metastasis (GCPM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Can a Triple-Action therapy tackle stomach Cancer's spread?

Disease control Not yet recruiting

This phase II trial is testing whether a combination of low-dose radiation, an immunotherapy drug (serplulimab), and chemotherapy can help people with stomach cancer that has spread to the lining of the abdomen (peritoneal metastasis). The study enrolls adults with HER2-negative …

Matched conditions: GASTRIC CANCER PERITONEAL METASTASIS (GCPM)

Phase 2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control

Last updated Aug 27, 2026 00:00 UTC

Gastric cancer peritoneal metastasis (GCPM)

Get alerted when new Gastric cancer peritoneal metastasis (GCPM) trials appear

Can a Triple-Action therapy tackle stomach Cancer's spread?